Peking Union Medical College Hospital clinical trial pipeline

19 trials changed in the last 30 days: 3 stopped, 6 with notable changes, 10 with minor changes only.

1. Stopped

   Cohort Study on the Safety and Efficacy of XH-02 in Treating…Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

   Recruitment suspended

   Sponsor's reason: Enrollment temporarily suspended in accordance with a newly implemented regulation, State Council Decree No. 818, on clinical research and clinical translation of new biomedical technologies; pending review and approval.

   Peking Union Medical College Hospital·Phase 2· NCT07540286· Registry history of NCT07540286 on ClinicalTrials.gov (opens the registry)

   Updated Sep 28, 2026

2. Stopped

   Subcutaneous Injection of XH-02 · Adult Hypoparathyroidism

   Recruitment suspended

   Sponsor's reason: Enrollment temporarily suspended in accordance with a newly implemented regulation, State Council Decree No. 818, on clinical research and clinical translation of new biomedical technologies; pending review and approval.

   Also in this update: Primary completion pushed from May 31, 2026 to May 30, 2027; Completion pushed from Jun 30, 2026 to Aug 30, 2027

   Peking Union Medical College Hospital·Phase 1/2· NCT07530705· Registry history of NCT07530705 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

3. Stopped

   XH02 · XH02 · Hypoparathyroidism

   Recruitment suspended

   Sponsor's reason: Enrollment temporarily suspended in accordance with a newly implemented regulation, State Council Decree No. 818, on clinical research and clinical translation of new biomedical technologies; pending review and approval.

   Also in this update: Primary completion pushed from Jul 15, 2026 to May 30, 2027; Completion pushed from Jul 30, 2026 to Aug 30, 2027

   Peking Union Medical College Hospital·Early Phase 1· NCT07197450· Registry history of NCT07197450 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

4. Notable

   Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA)…Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA) · Cystic Fibrosis

   Primary completion pushed from May 10, 2026 to Dec 13, 2026

   Also in this update: Trial status changed: Not Yet Recruiting → Active, Not Recruiting

   Peking Union Medical College Hospital·Early Phase 1· NCT06963008· Registry history of NCT06963008 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

5. Notable

   Faecal Microbiota Transplantation · Refractory Rheumatoid Arthritis

   Primary completion pushed from Jun 1, 2028 to Jun 30, 2031

   Also in this update: Recruitment opened; Completion pushed from Dec 31, 2028 to Dec 31, 2031

   Peking Union Medical College Hospital·Phase 2· NCT07639177· Registry history of NCT07639177 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

6. Notable

   Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging…Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

   Primary and study completion pushed from Dec 1, 2025 to Dec 31, 2027

   Peking Union Medical College Hospital·Early Phase 1· NCT06411678· Registry history of NCT06411678 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

7. Notable

   Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients…Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years

   Recruitment opened

   Peking Union Medical College Hospital·Early Phase 1· NCT07485543· Registry history of NCT07485543 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

8. Notable

   SIB-NCRT · Simultaneous Boost in Neoadjuvant Radiotherapy for…SIB-NCRT · Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer

   Recruitment opened

   Peking Union Medical College Hospital·Phase 2· NCT07200141· Registry history of NCT07200141 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

9. Notable

   Impact of LBBAP vs RVP on the Incidence of New-onset Atrial…Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation · Atrioventricular Block

   Recruitment opened

   Peking Union Medical College Hospital·Not applicable· NCT06023784· Registry history of NCT06023784 on ClinicalTrials.gov (opens the registry)

   Updated Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.